Synlogic, Inc. (SYBX) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
SYBX Revenue Analysis (2013–2024)
As of March 5, 2026, Synlogic, Inc. (SYBX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, SYBX's 5-year compound annual growth rate (CAGR) stands at -67.6%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $3.4 million in 2023.
When compared to Healthcare sector peers including ARMP (-7.6% YoY), EVGN (-26.2% YoY), and ELAB (-179.8% YoY). Compare SYBX vs ARMP →
Peer Comparison
Compare SYBX's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SYBXCurrent | $0 | - | -67.6% | -511875.0% | |
 ARMP | $5M | -7.6% | - | -820.2% | |
 EVGN | $9M | -26.2% | +62.4% | -255.4% | |
 ELAB | $2M | -179.8% | - | -75.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $8K | -99.8% | $8K | 100.0% | $-40,950,000 | -511875.0% |
| 2023 | $3.4M | +185.7% | $3.4M | 100.0% | $-55,161,000 | -1636.3% |
| 2022 | $1.2M | -32.7% | $1.2M | 100.0% | $-67,419,000 | -5713.5% |
| 2021 | $1.8M | +221.8% | $1.8M | 100.0% | $-60,765,000 | -3464.4% |
| 2020 | $545K | -75.5% | $545K | 100.0% | $-60,466,000 | -11094.7% |
| 2019 | $2.2M | -11.7% | $2.2M | 100.0% | $-54,409,000 | -2446.4% |
| 2018 | $2.5M | +3.1% | $-12,377,000 | -491.2% | $-51,230,000 | -2032.9% |
| 2017 | $2.4M | +450.5% | $2.4M | 100.0% | $-40,824,000 | -1670.4% |
| 2016 | $444K | - | $285K | 64.2% | $-26,618,000 | -5995.0% |
| 2015 | $0 | - | $-54,000 | - | $-25,027,000 | - |
See SYBX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SYBX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SYBX vs AGIO
See how SYBX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SYBX's revenue growth accelerating or slowing?
SYBX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: -67.6%.
What is SYBX's long-term revenue growth rate?
Synlogic, Inc.'s 5-year revenue CAGR of -67.6% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SYBX's revenue distributed by segment?
SYBX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.